Overview
Retatrutide is a research peptide designed to engage three metabolic hormone receptors: GIP, GLP-1, and glucagon receptors. The pre-filled pen contains 40mg total, divided into four 10mg portions, giving researchers a standardized format for studying multi-receptor signaling within one compound.
Research Focus
WHAT THIS FORMULA FEATURES
Combined GIPR, GLP1R, and GCGR activity in one molecule, allowing direct study of how incretin pathways and glucagon-receptor signaling interact rather than testing each receptor system in isolation.
EXPECTED RESEARCH READOUTS
Common research endpoints include receptor-specific cAMP responses, comparative potency across GIPR/GLP1R/GCGR, insulin- and glucagon-related responses in suitable models, glucose-handling measurements, substrate-metabolism markers, and pathway-selectivity studies.
Key Characteristics
PRODUCT CONFIGURATION
Total dosage: 40mg
Package: 1 pre-filled research pen
Configuration: 4 × 10mg
Pen color: Apple Green
RESEARCH PROFILE
Compound profile: Triple GIP / GLP-1 / glucagon receptor agonist research peptide
Format: Pre-filled research pen
Fulfilment: Fast Stock across local locations + Global shipping
Transit: Cold-chain packed with ice packs
Research use only. Not approved for human or animal use.
